---
title: "HROW.US (HROW.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/HROW.US/news.md"
symbol: "HROW.US"
name: "HROW.US"
parent: "https://longbridge.com/en/quote/HROW.US.md"
datetime: "2026-06-14T03:01:55.959Z"
locales:
  - [en](https://longbridge.com/en/quote/HROW.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/HROW.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/HROW.US/news.md)
---

# HROW.US (HROW.US) — Related News

### [Harrow Adds Another Piece To Ophthalmology Strategy](https://longbridge.com/en/news/289489814.md)
*2026-06-11T15:42:29.000Z*
> Harrow Inc. announced the relaunch of VERKAZIA (cyclosporine ophthalmic emulsion) 0.1% for treating vernal keratoconjunc

### [Alpha Buying: When CEOs and CFOs Buy Together](https://longbridge.com/en/news/287949639.md)
*2026-05-28T16:18:14.000Z*
> Recent insider buying by CEOs and CFOs at several companies signals confidence in future stock performance. Notable exam

### [Harrow (HROW) Is Up 6.8% After Reaffirming 2026 Revenue Outlook Despite Wider Q1 Losses - What's Changed](https://longbridge.com/en/news/287551067.md)
*2026-05-25T20:38:30.000Z*
> Harrow, Inc. reported a Q1 2026 revenue of $44.2 million, down from $47.83 million, with a net loss widening to $27.6 mi

### [Harrow (HROW) Q1 Loss Of US$27.6 Million Rekindles Profitability Concerns](https://longbridge.com/en/news/286182766.md)
*2026-05-13T02:06:33.000Z*
> Harrow (HROW) reported a Q1 loss of US$27.6 million, raising concerns about its profitability. Revenue fell to US$44.2 m

### [Top 10 US Stock Losers (5.12)](https://longbridge.com/en/news/286163538.md)
*2026-05-12T22:01:01.000Z*
> Power Solutions(PSIX) fell 39.15%, with a trading turnover 202.8 Million USD, and a year-to-date fell 33.5%. ZoomInfo Te

### [Harrow expects second-quarter revenue of $71 million to $81 million, reiterating its full-year performance guidance](https://longbridge.com/en/news/286147021.md)
*2026-05-12T19:45:32.000Z*
> Harrow Inc. expects second-quarter revenue to be between $71 million and $81 million, and reaffirms its full-year perfor

### [Transcript: Harrow Q1 2026 Earnings Conference Call](https://longbridge.com/en/news/286127404.md)
*2026-05-12T15:29:47.000Z*
> Harrow Inc (NASDAQ:HROW) reported Q1 2026 revenues of $44.2 million, with an adjusted EBITDA of -$12.7 million, impacted

### [Harrow | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 44.2 M](https://longbridge.com/en/news/285993197.md)
*2026-05-11T20:34:59.000Z*
### [](https://longbridge.com/en/news/285994905.md)
*2026-05-11T20:27:52.000Z*
> Harrow shares are trading lower after the company reported worse-than-expected Q1 financial results.